Inqovi Maintenance Therapy in Myeloid Neoplasms

NCT04980404 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia
Stem Cell Leukemia

Interventions

DRUG: Inqovi

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]